344 related articles for article (PubMed ID: 38571961)
21. Progress and perspective of organoid technology in cancer-related translational medicine.
Lin Y; Jiang L; He Q; Yuan M; Cao J
Biomed Pharmacother; 2022 May; 149():112869. PubMed ID: 35358798
[TBL] [Abstract][Full Text] [Related]
22. Personalized Cancer Medicine: An Organoid Approach.
Aboulkheyr Es H; Montazeri L; Aref AR; Vosough M; Baharvand H
Trends Biotechnol; 2018 Apr; 36(4):358-371. PubMed ID: 29366522
[TBL] [Abstract][Full Text] [Related]
23. Mini-organs with big impact: Organoids in liver cancer studies.
Khawar MB; Wang Y; Majeed A; Afzal A; Haneef K; Sun H
Oncol Res; 2023; 31(5):677-688. PubMed ID: 37547759
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer patient-derived organoids: detailed outcome from a prospective cohort of 81 clinical specimens.
Servant R; Garioni M; Vlajnic T; Blind M; Pueschel H; Müller DC; Zellweger T; Templeton AJ; Garofoli A; Maletti S; Piscuoglio S; Rubin MA; Seifert H; Rentsch CA; Bubendorf L; Le Magnen C
J Pathol; 2021 Aug; 254(5):543-555. PubMed ID: 33934365
[TBL] [Abstract][Full Text] [Related]
25. Cancer organoids: A platform in basic and translational research.
Ma X; Wang Q; Li G; Li H; Xu S; Pang D
Genes Dis; 2024 Mar; 11(2):614-632. PubMed ID: 37692477
[TBL] [Abstract][Full Text] [Related]
26. Organoids as research models for hepatocellular carcinoma.
Yu JH; Ma S
Exp Cell Res; 2022 Feb; 411(1):112987. PubMed ID: 34942189
[TBL] [Abstract][Full Text] [Related]
27. Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers.
Nguyen R; Bae SDW; Zhou G; Read SA; Ahlenstiel G; George J; Qiao L
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188350. PubMed ID: 32007597
[TBL] [Abstract][Full Text] [Related]
28. Next generation organoids for biomedical research and applications.
Lou YR; Leung AW
Biotechnol Adv; 2018; 36(1):132-149. PubMed ID: 29056474
[TBL] [Abstract][Full Text] [Related]
29. A synopsis of prostate organoid methodologies, applications, and limitations.
Gleave AM; Ci X; Lin D; Wang Y
Prostate; 2020 May; 80(6):518-526. PubMed ID: 32084293
[TBL] [Abstract][Full Text] [Related]
30. Cancer-associated fibroblasts nurture LGR5 marked liver tumor-initiating cells and promote their tumor formation, growth, and metastasis.
Zhang M; Fang Y; Fu X; Liu J; Liu Y; Zhu Z; Ni Y; Yao M; Pan Q; Cao W; Li Z; Dong C
Cancer Med; 2023 Sep; 12(17):18032-18049. PubMed ID: 37578396
[TBL] [Abstract][Full Text] [Related]
31. Advances in biomimetic hydrogels for organoid culture.
Luo L; Liu L; Ding Y; Dong Y; Ma M
Chem Commun (Camb); 2023 Aug; 59(64):9675-9686. PubMed ID: 37455615
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response.
Piro G; Agostini A; Larghi A; Quero G; Carbone C; Esposito A; Rizzatti G; Attili F; Alfieri S; Costamagna G; Tortora G
Front Med (Lausanne); 2021; 8():793144. PubMed ID: 35004765
[TBL] [Abstract][Full Text] [Related]
33. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
[TBL] [Abstract][Full Text] [Related]
34. Standardization and Maintenance of 3D Canine Hepatic and Intestinal Organoid Cultures for Use in Biomedical Research.
Gabriel V; Zdyrski C; Sahoo DK; Dao K; Bourgois-Mochel A; Kopper J; Zeng XL; Estes MK; Mochel JP; Allenspach K
J Vis Exp; 2022 Jan; (179):. PubMed ID: 35156656
[TBL] [Abstract][Full Text] [Related]
35. Organoid Models for Precision Cancer Immunotherapy.
Sun CP; Lan HR; Fang XL; Yang XY; Jin KT
Front Immunol; 2022; 13():770465. PubMed ID: 35450073
[TBL] [Abstract][Full Text] [Related]
36. Highly reproducible and cost-effective one-pot organoid differentiation using a novel platform based on PF-127 triggered spheroid assembly.
Zhang XS; Xie G; Ma H; Ding S; Wu YX; Fei Y; Cheng Q; Huang Y; Wang Y
Biofabrication; 2023 Aug; 15(4):. PubMed ID: 37552975
[TBL] [Abstract][Full Text] [Related]
37. The "3Ds" of Growing Kidney Organoids: Advances in Nephron Development, Disease Modeling, and Drug Screening.
Chambers BE; Weaver NE; Wingert RA
Cells; 2023 Feb; 12(4):. PubMed ID: 36831216
[TBL] [Abstract][Full Text] [Related]
38. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.
Skardal A; Shupe T; Atala A
Drug Discov Today; 2016 Sep; 21(9):1399-1411. PubMed ID: 27422270
[TBL] [Abstract][Full Text] [Related]
39. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.
Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI
OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609
[TBL] [Abstract][Full Text] [Related]
40. Organoid technology in female reproductive biomedicine.
Heidari-Khoei H; Esfandiari F; Hajari MA; Ghorbaninejad Z; Piryaei A; Baharvand H
Reprod Biol Endocrinol; 2020 Jun; 18(1):64. PubMed ID: 32552764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
